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I would like to describe briefly some preliminary serologic data that we have
generated recently which may have some relevance to the cytomegalovirus (CMV)
vaccine question. The CMV purification scheme used at the Community Blood
Center starts with clarified, extracellular AD169 which is concentrated by ultrafil-
tration and then subjected to density gradient centrifugation in 20 to 60 percent su-
crose gradients for 1 hr at 31,000 rpm in the SW50.1 rotor. Three light-scattering
bqnds can be identified, the bottom most of which, at 45% sucrose, is comprised
mainly ofdense bodies. Dense bodies are electron-dense cytoplasmic material which
has been described in cells infected in vitro with a number of herpes viruses. They
have been seen in human CMV (1), rat CMV (2), murine CMV (3), varicella-zoster
virus (4), Lucke virus offrogs (5), and Marek's disease virus (6). Although lysosomes
are present in CMV-infected cells, they are morphologically distinct from dense
bodies, a fact emphasized by Craighead, et al. (7) in a very careful study of dense
bodies in cells infected with human CMV. They found no evidence that dense bodies
contain lipids or carbohydrates and thus concluded that they are comprised largely of
proteins. No comments were made as to their possible nucleic acid content.
An interesting observation made by Craighead and co-workers was that by im-
mune electron microscopy they could identify at least one cross-reactive antigenic
determinant on enveloped CMV virions and dense bodies. This observation prompted
us to use the material in the lowest sucrose band, that is, the one composed primarily
ofdense bodies, as a complement-fixation (CF) antigen to see if we could identify an-
tibodies in human sera that would react with dense bodies. Table 1 summarizes the
results of this experiment. Patient C is 6-months convalescent from a documented
case ofCMV mononucleosis whose serum has consistently given a titer of 1:64 in the
Laboratory Branch Complement Fixation (LBCF) test against a "standard" AD169
CF antigen, i.e., an alkaline glycine buffer extract ofsonicated, infected human fibro-
blasts. When dense bodies were used as the CF antigen, this serum had a titer of
1:32. Patient H underwent a hysterectomy and was followed prospectively for evi-
dence of transfusion-associated CMV infection. Her pretransfusion CMV CF titer
was 1:64 and rose to 1:256 13 weeks after transfusion, at which time she was excret-
ing CMV in her urine. Testing of these sera using dense bodies as the CF antigen
yielded titers of 1:16 and 1:64, respectively. Patient M was referred to us with hetero-
phile negative mononucleosis which was subsequently diagnosed as due to CMV. The
virus was initially isolated from her blood and urine. A urine specimen taken 3 weeks
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TABLE 1
Comparative CF Antibody Titers ofSelected Sera versus Standard CMV CF Antigen
and "Dense Body" CF Antigen
Reciprocal CF antibody titer Reciprocal CF antibody titer
Serum against standard CMV antigen against "dense body" antigen
Patient C 64 32
Pretransfusion, patient H (1-30-75) 64 16
Posttransfusion, patient H (4-30-75) 256 64
Patient M, 1st serum (4-30-74) >512 <4
Patient M, 2nd serum (5-20-74) >512 8
Patient M, 3rd serum (7-16-74) 256 16
Guinea pig, hyperimmune 512 512
'CMV strain AD169 was used to produce the standard CF antigen. Dense bodies were derived from
AD169-infected human embryonic tonsil fibroblasts.
later yielded CMV, while both throat and urine specimens were CMV-positive at 11
weeks followup. Her serum antibody titers against the standard CMV CF antigen
were > 1:512, > 1:512, and 1:256, whereas the corresponding titers against the dense
body antigen were < 1:4, 1:8, and 1:16.
Finally, a guinea pig hyperimmune serum which we prepared against middle band
material, i.e., the density gradient fraction largely containing enveloped virions, had a
CMV CF titer of 1:512 against both the standard antigen and a CF antigen consisting
ofdense bodies derived from CMV-infected human fibroblasts.
Thus, it seems clear that human sera do have antibodies which react with "puri-
fied" dense bodies and that diagnostically significant antibody rises can be picked up
using them as the CF antigen, even in the face ofpersistently high titers against the
standard CMV CF antigen. In closing, I would like to suggest that dense bodies not
be overlooked as a potentially rich source ofimmunogenic material for use as a possi-
ble vaccine.
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